REGULATORY
Japan Inks Memorandums of Cooperation on Pharmacopoeias with US, Europe, China
The Ministry of Health, Labor and Welfare (MHLW) said on September 23 that it has concluded memorandums of cooperation for pharmacopoeias with counterparts of the US, Europe, and China at the International Meeting of World Pharmacopoeias held earlier this month.…
To read the full story
Related Article
- International Meeting of World Pharmacopoeias OKs GPhP Draft
September 16, 2016
REGULATORY
- Japan Targets Global-Level Growth for Domestic Patented Drug Market
June 25, 2026
- Paxlovid, Awiqli Braced for NHI Price Cuts after CEAs
June 25, 2026
- Drug Pricing to Be Applied to Oncolys Oncolytic Virus Therapy
June 25, 2026
- Japan Diet Begins Deliberations on Immunization Act Revision
June 25, 2026
- Expert Calls for AMR Ecosystem to Boost Japan Antibiotic Innovation
June 25, 2026
Recent trends are creating a fascinating push-and-pull effect in the talent market. We’re seeing more positions opening up, but also a greater number of candidates available, particularly in the fields of rare diseases and oncology. This “more positions, more candidates”…





